Early vascular ageing and hypertension - A new model for understanding cardiovascular risk

Current Hypertension Reviews

Volumn 3, Issue 2, 2007, Pages 133-136

  Nilsson, Peter M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arterial ageing; Arterial pressure; Coronary heart disease; Endothelin 1; Intima media thickness; Spontaneously hypertensive rats

Indexed keywords

ANTIHYPERTENSIVE AGENT; BOSENTAN; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; METFORMIN; N(G) NITROARGININE METHYL ESTER; PLACEBO; PRAVASTATIN; VARENICLINE;

AGING; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG MECHANISM; ENVIRONMENTAL FACTOR; HEART INFARCTION; HEREDITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SENESCENCE; SMOKING CESSATION; SOCIAL ASPECT; STRESS; TELOMERE; TOBACCO DEPENDENCE;

EID: 34249002106     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340207780598446     Document Type: Review

References (48)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
2. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM Pannier B, Benetos A. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47: 72-5.
3. Ghiadoni L, Virdis A. Aging and hypertension: what about the endothelium? J Hypertens 2006; 24: 1243-4.
4. Booth GL, Kapral NK Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006; 368: 29-36.
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
6. Edward G. Lakatta EG, Najjar SS. Vascular Aging: An Emerging New Global Cardiovascular Risk. (Abstract). The Valencia Forum, 2002. http://www.valenciaforum.com/Keynotes/e1.html.
7. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005; 46: 454-62.
8. Aviv A, Levy D, Mangel M. Growth, telomere dynamics and successful and unsuccessful human aging. Mech Ageing Dev 2003; 124: 829-37.
9. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 2001; 358: 472-3.
10. Benetos A, Gardner JP, Zureik K et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004; 43: 182-5.
11. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-4.
12. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, Aviv A. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998; 47:482-6.
13. Obana N, Takagi S, Kinouchi Y, et al. Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med 2003; 42: 150-3.
14. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842-6.
15. Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546-50.
16. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X, Berenson GS, Aviv A. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171-7.
17. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004; 101: 17312-5.
18. Epel ES, Lin J, Wilhelm FH, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006; 31: 277-87.
19. Bairey Merz CN, Dwyer J, Nordstrom CK, Walton KG, Salerno JW, Schneider RH. Psychosocial stress and cardiovascular disease: pathophysiological links. Behav Med 2002; 27: 141-7.
20. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am J Epidemiol 2007; 165: 14-21
21. Cawthon RK Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-5.
22. Perez-Rivero G, Ruiz-Torres MP, Rivas-Elena JV, et al. Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation 2006; 114: 309-17.
23. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831-7.
24. Fuster JJ, Andres V. Telomere biology and cardiovascular disease. Circ Res 2006; 99:1167-80.
25. Matthews C, Gorenne I, Scott S, et al Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006; 99: 156-64.
26. Kaplan GA, Keil JE. Socio-economic factors and cardiovascular disease: a review of the literature. Circulation 1993; 88:1973-1998.
27. Nilsson P, Nilsson J-Å, Hedblad B, Östergren P-O, Berglund G. Social mobility, marital status and mortality risk in an adult life course perspective - the Malmö Preventive Project. Scand J Public Health 2005; 33: 412-23.
28. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 1996; 144: 934-42.
29. Barker DJP (ed). Fetal and infant origins of adult disease. 1st edition. British Medical Journal. London, 1992.
30. Eriksson JG, Forsen TJ. Childhood growth and coronary head disease in later life. Ann Med 2002; 34: 157-61.
31. Nilsson P. Premature ageing - the link between psychosocial risk factors and disease? Med Hypotheses 1996; 47: 39-42.
32. Nilsson P, Nyberg P, Östergren P-O. Susceptibility to a psychological stress test in young males is associated with low birth weight. Int J Epidemiol 2001; 30: 75-80.
33. Theorell T, Svensson J, Knox S, Ahlborg B. Blood pressure variations across areas in the greater Stockholm region: analysis of 74,000 18-year-old men. Soc Sci Med 1982; 16: 469-73.
34. Nilsson P, Söderström M, Ericson A, Östergren P-O, Allebeck P. Low birth weight is associated with elevated systolic blood pressure - a study of 149,378 male Swedish military conscripts. J Hypertens 1997; 15: 1627-31.
35. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. For the Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368: 1673-9.
36. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006; 56-63.
37. Spyridopoulos I, Haendeler J, Urbich C, Brummendorf TH, Oh H, Schneider MD, Zeiher AM, Dimmeler S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110: 3136- 42.
38. Efficacy and safety of cholesterol-lowering treatment prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Cholesterol Treatment Trialists' (CTT) Collaborators. Lancet 2005; 366: 1267-1278.
39. Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 2006; 368: 581-8.
40. Brouilette SW, Moore SJ, MacMahon AD, Thompson JR, Shepherd J, Packard C, Samani NJ: for the West of Scotland Coronary Protection Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Coronary Protection Study: a nested case-control study. Lancet 2007; 369: 107-14.
41. Dormandy JA, Charbonnel B, Eckland DJA, et al. on behalf of the PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes m the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005; 366: 1279-1289.
42. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators; Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368: 1096-105.
43. Home PD, Pocock SJ, Beek-Nielsen H, et al. Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia. 2005; 48: 1726-35.
44. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
45. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006; 368: 1651-9.
46. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357-62.
47. Abraham A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med 2002; 80: 689-695.
48. Asmar R. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications. Am J Cardiovasc Drugs 2001; 1: 387-97.